NAYA Biosciences regains Nasdaq equity compliance; faces one-year monitor

INVO Fertility, Inc.

Received Nasdaq notice dated Oct 30, 2024 confirming compliance with Listing Rule 5550(b)(1) (Equity Rule).
Compliance follows June 18, 2024 Panel decision; company under mandatory panel monitor for one year.
No financial results or operational updates disclosed in this filing.

item 8.01 item 9.01

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-044278

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.